Difference between revisions of "Prednisolone (Millipred)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
m
Line 28: Line 28:
  
 
==Patient drug information==
 
==Patient drug information==
*[https://chemocare.com/chemotherapy/drug-info/Prednisolone.aspx Prednisolone (Millipred) patient drug information (Chemocare)]<ref>[https://chemocare.com/chemotherapy/drug-info/Prednisolone.aspx Prednisolone (Millipred) patient drug information (Chemocare)]</ref>
+
*[https://chemocare.com/chemotherapy/druginfo/prednisolone Prednisolone (Millipred) patient drug information (Chemocare)]<ref>[https://chemocare.com/chemotherapy/druginfo/prednisolone Prednisolone (Millipred) patient drug information (Chemocare)]</ref>
 
*[http://www.uptodate.com/contents/prednisolone-patient-drug-information Prednisolone (Millipred) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/prednisolone-patient-drug-information Prednisolone (Millipred) patient drug information (UpToDate)]</ref>
 
*[http://www.uptodate.com/contents/prednisolone-patient-drug-information Prednisolone (Millipred) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/prednisolone-patient-drug-information Prednisolone (Millipred) patient drug information (UpToDate)]</ref>
 
==History of changes in EMA indication==
 
==History of changes in EMA indication==

Revision as of 23:07, 2 September 2023

General information

Class/mechanism: Corticosteroid, glucocorticoid.[1][2][3]
Route: PO, gtt (ophthalmic eye drops)
Extravasation: n/a

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]

Diseases for which it is used

Diseases for which it was used

Patient drug information

History of changes in EMA indication

  • 1956-07-13: EURD

History of changes in PMDA indication

  • 2011-09-16: New indication for the treatment of multiple myeloma.
  • 2015-06-26: revised indications and a new dosage for the treatment of malignant lymphoma and similar diseases (closely-related diseases).

Also known as

  • Generic names: delta(1)hydrocortisone, delta1-dehydro-hydrocortisone, deltahydrocortisone, metacortandralone, prednisolone acetate, prednisolone tebutate
  • Brand names: Adnisolone, Aprednislon, Capsoid, Cortalone, Cortisolone, Cotolone, Dacortin H, Decaprednil, Decortin H, Delta-Cortef, Deltacortril, Delta-Diona, Delta-Phoricol, Deltasolone, Deltidrosol, Dhasolone, Di-Adreson-F, Dontisolon D, Estilsona, Fisopred, Frisolona, Gupisone, Hostacortin H, Hydeltra, Hydeltrasol, Klismacort, Kuhlprednon, Lenisolone, Lepi-Cortinolo, Linola-H N, Linola-H-Fett N, Longiprednil, Medicort, Meticortelone, Meti-derm, Millipred, Opredsone, Orapred, Panafcortelone, Predcor, Predicort, Precortisyl, Pred-Clysma, Predeltilone, Predni-Coelin, Prednicortelone, Predni-Helvacort, Predonine, Prelone, Prenilone, Pri-Cortin, Veripred

References